CXC chemokine ligand 2 induced by receptor activator of NF-κB ligand enhances osteoclastogenesis

Journal of Immunology

Volumn 184, Issue 9, 2010, Pages 4717-4724

  Ha, Jeongim ^a   Choi, Hyo Sun ^a   Lee, Youngkyun ^a   Kwon, Hyung Joo ^c   Song, Yeong Wook ^b   Kim, Hong Hee ^a  

^a School of Dentistry   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Hallym University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL2 CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NEUTRALIZING ANTIBODY; OSTEOCLAST DIFFERENTIATION FACTOR; STRESS ACTIVATED PROTEIN KINASE; CXCL2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DESTRUCTION; BONE EROSION; BONE MARROW; CELL ACTIVATION; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; IN VIVO STUDY; MACROPHAGE; MOUSE; NONHUMAN; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; STEM CELL; SYNOVIAL FLUID; UPREGULATION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CELL MOTION; ENZYMOLOGY; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; OSTEOCLAST; OSTEOLYSIS; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BONE RESORPTION; CELL ADHESION; CELL DIFFERENTIATION; CELL LINE; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CXCL2; HUMANS; MICE; MICE, INBRED ICR; OSTEOCLASTS; RANK LIGAND; STEM CELLS;

EID: 77954502217     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902444     Document Type: Article

References (22)

1. Hadjidakis, D. J., and I. I. Androulakis. 2006. Bone remodeling. Ann. N. Y. Acad. Sci. 1092: 385-396.
2. Suda, T., N. Takahashi, N. Udagawa, E. Jimi, M. T. Gillespie, and T. J. Martin. 1999. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20: 345-357.
3. Nakamura, I., G. A. Rodan, and T. Duong. 2003. Regulatory mechanism of osteoclast activation. J. Electron Microsc. (Tokyo) 52: 527-533.
4. Kim, M. S., C. J. Day, and N. A. Morrison. 2005. MCP-1 is induced by receptor activator of nuclear factor-kappaB ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation. J. Biol. Chem. 280: 16163-16169.
5. Ishida, N., K. Hayashi, A. Hattori, K. Yogo, T. Kimura, and T. Takeya. 2006. CCR1 acts downstream of NFAT2 in osteoclastogenesis and enhances cell migration. J. Bone Miner. Res. 21: 48-57.
6. Lean, J. M., C. Murphy, K. Fuller, and T. J. Chambers. 2002. CCL9/MIP-1gamma and its receptor CCR1 are the major chemokine ligand/receptor species expressed by osteoclasts. J. Cell. Biochem. 87: 386-393.
7. Kwak, H. B., H. Ha, H. N. Kim, J. H. Lee, H. S. Kim, S. Lee, H. M. Kim, J. Y. Kim, H. H. Kim, Y. W. Song, and Z. H. Lee. 2008. Reciprocal cross-talk between RANKL and interferon-gamma-inducible protein 10 is responsible for bone-erosive experimental arthritis. Arthritis Rheum. 58: 1332-1342.
8. De Klerck, B., L. Geboes, S. Hatse, H. Kelchtermans, Y. Meyvis, K. Vermeire, G. Bridger, A. Billiau, D. Schols, and P. Matthys. 2005. Pro-inflammatory properties of stromal cell-derived factor-1 (CXCL12) in collagen-induced arthritis. Arthritis Res. Ther. 7: R1208-R1220.
9. Wolpe, S. D., and A. Cerami. 1989. Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines. FASEB J. 3: 2565-2573.
10. Li, X., D. Klintman, Q. Liu, T. Sato, B. Jeppsson, and H. Thorlacius. 2004. Critical role of CXC chemokines in endotoxemic liver injury in mice. J. Leukoc. Biol. 75: 443-452.
11. Ren, X., A. Carpenter, C. Hogaboam, and L. Colletti. 2003. Mitogenic properties of endogenous and pharmacological doses of macrophage inflammatory protein-2 after 70% hepatectomy in the mouse. Am. J. Pathol. 163: 563-570.
12. Riaz, A. A., R. Schramm, T. Sato, M. D. Menger, B. Jeppsson, and H. Thorlacius. 2003. Oxygen radical-dependent expression of CXC chemokines regulate ischemia/reperfusion-induced leukocyte adhesion in the mouse colon. Free Radic. Biol. Med. 35: 782-789.
13. Ha, J., H. S. Choi, Y. Lee, Z. H. Lee, and H. H. Kim. 2009. Caffeic acid phenethyl ester inhibits osteoclastogenesis by suppressing NF kappaB and down-regulating NFATc1 and c-Fos. Int. Immunopharmacol. 9: 774-780.
14. Chang, E. J., J. Ha, H. Huang, H. J. Kim, J. H. Woo, Y. Lee, Z. H. Lee, J. H. Kim, and H. H. Kim. 2008. The JNK-dependent CaMK pathway restrains the reversion of committed cells during osteoclast differentiation. J. Cell Sci. 121: 2555-2564.
15. Kim, D. S., J. H. Han, and H. J. Kwon. 2003. NF-kappaB and c-Jun-dependent regulation of macrophage inflammatory protein-2 gene expression in response to lipopolysaccharide in RAW 264.7 cells. Mol. Immunol. 40: 633-643.
16. Jimi, E., S. Akiyama, T. Tsurukai, N. Okahashi, K. Kobayashi, N. Udagawa, T. Nishihara, N. Takahashi, and T. Suda. 1999. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function. J. Immunol. 163: 434-442. (Pubitemid 29295871)
17. Boyce, B. F., E. M. Schwarz, and L. Xing. 2006. Osteoclast precursors: cytokine-stimulated immunomodulators of inflammatory bone disease. Curr. Opin. Rheumatol. 18: 427-432.
18. Wang, B., D. T. Hendricks, F. Wamunyokoli, and M. I. Parker. 2006. A growth-related oncogene/CXC chemokine receptor 2 autocrine loop contributes to cellular proliferation in esophageal cancer. Cancer Res. 66: 3071-3077.
19. Wang, L., M. Fuster, P. Sriramarao, and J. D. Esko. 2005. Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses. Nat. Immunol. 6: 902-910.
20. Coelho, F. M., V. Pinho, F. A. Amaral, D. Sachs, V. V. Costa, D. H. Rodrigues, A. T. Vieira, T. A. Silva, D. G. Souza, R. Bertini, et al. 2008. The chemokine receptors CXCR1/CXCR2 modulate antigen-induced arthritis by regulating adhesion of neutrophils to the synovial microvasculature. Arthritis Rheum. 58: 2329-2337.
21. Kasama, T., R. M. Strieter, N. W. Lukacs, P. M. Lincoln, M. D. Burdick, and S. L. Kunkel. 1995. Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. J. Clin. Invest. 95: 2868-2876.
22. Podolin, P. L., B. J. Bolognese, J. J. Foley, D. B. Schmidt, P. T. Buckley, K. L. Widdowson, Q. Jin, J. R. White, J. M. Lee, R. B. Goodman, et al. 2002. A potent and selective nonpeptide antagonist of CXCR2 inhibits acute and chronic models of arthritis in the rabbit. J. Immunol. 169: 6435-6444.